CD19 and enterocolitis: However, given that BCMA expression is similar in tonsillar and enteric tissue [13] and that similar presentations have occurred with CD19-directed CAR-T therapy [6–8], direct on-target toxicity does not seem to fully explain IEC-associated enterocolitis.